Jason Haas - 29 Jun 2022 Form 3 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Role
Director
Signature
By: Charles S. Berkman For: Jason Haas
Issuer symbol
LGND
Transactions as of
29 Jun 2022
Net transactions value
$0
Form type
3
Filing time
29 Jun 2022, 19:33:39 UTC
Previous filing
17 Feb 2022
Next filing
11 Oct 2022

No securities are beneficially owned.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney